CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-24 | NIES ALAN S Director | Exercise or conversion | +10,638 | 27,720 | ||
| 2021-04-24 | NIES ALAN S Director | Exercise or conversion · Restricted Stock Units | −10,638 | 0 | ||
| 2021-04-24 | LEFKOWITZ ROBERT J MD Director | Exercise or conversion | +10,638 | 27,006 | ||
| 2021-04-24 | LEFKOWITZ ROBERT J MD Director | Exercise or conversion · Restricted Stock Units | −10,638 | 0 | ||
| 2021-04-24 | DEBBANE RAYMOND Director | Exercise or conversion | +10,638 | 327,521 | ||
| 2021-04-24 | DEBBANE RAYMOND Director | Exercise or conversion · Restricted Stock Units | −10,638 | 0 | ||
| 2021-04-24 | BARKER SAM L Director | Exercise or conversion | +10,638 | 66,291 | ||
| 2021-04-24 | BARKER SAM L Director | Exercise or conversion · Restricted Stock Units | −10,638 | 0 | ||
| 2021-04-24 | Amouyal Philippe Director | Exercise or conversion | +10,638 | 27,006 | ||
| 2021-04-24 | Amouyal Philippe Director | Exercise or conversion · Restricted Stock Units | −10,638 | 0 | ||
| 2021-03-15 | Tessmer James F VP, Finance & Accounting | Sale | −10,912 | $6.90 | $75K | 71,766 |
| 2021-03-15 | Tessmer James F VP, Finance & Accounting | Exercise or conversion | +12,000 | $3.31 | $40K | 83,766 |
| 2021-03-15 | Tessmer James F VP, Finance & Accounting | Sale | −12,000 | $6.93 | $83K | 71,766 |
| 2021-03-15 | Tessmer James F VP, Finance & Accounting | Exercise or conversion · Stock Option (Right to Buy) | −12,000 | 50,980 | ||
| 2021-02-28 | WADE JEFFREY L EVP, Corp Adm Affairs and CFO | Exercise or conversion | +2,797 | 118,292 | ||
| 2021-02-28 | WADE JEFFREY L EVP, Corp Adm Affairs and CFO | Exercise or conversion | +9,555 | 127,847 | ||
| 2021-02-28 | WADE JEFFREY L EVP, Corp Adm Affairs and CFO | Exercise or conversion | +25,290 | 153,137 | ||
| 2021-02-28 | WADE JEFFREY L EVP, Corp Adm Affairs and CFO | Exercise or conversion | +30,467 | 183,604 | ||
| 2021-02-28 | WADE JEFFREY L EVP, Corp Adm Affairs and CFO | Shares withheld for taxes | −26,584 | $7.19 | $191K | 157,020 |
| 2021-02-28 | WADE JEFFREY L EVP, Corp Adm Affairs and CFO | Exercise or conversion · Restricted Stock Units | −2,797 | 0 |
Page 28 of 51 · 1,001 trades